Question:
Match the alkaloids with their synthesis precursors
(1) Pilocarpine (P) Necleotide (2) Connine (Q) Tryptophan (3) Caffine (R) Histadine (4) Yohimbine (S) Acetate derived
Match the alkaloids with their synthesis precursors
| (1) | Pilocarpine | (P) | Necleotide |
| (2) | Connine | (Q) | Tryptophan |
| (3) | Caffine | (R) | Histadine |
| (4) | Yohimbine | (S) | Acetate derived |
Updated On: Aug 11, 2024
- 1-S, 2-R, 3-P, 4-Q
- 1-S, 2-Q, 3-P, 4-R
- 1-S, 2-Q, 3-P, 4-R
- 1-R, 2-S, 3-P, 4-Q
Hide Solution
Verified By Collegedunia
The Correct Option is D
Solution and Explanation
The correct option is (D): 1-R, 2-S, 3-P, 4-Q
Was this answer helpful?
0
0
Top Questions on Alkaloids
- Identify the structure of the alkaloid having the following characteristics:
(A) It is a coca alkaloid having molecular formula \( \text{C}_9\text{H}_{11}\text{NO} \).
(B) As the free base, it rapidly racemizes.
(C) Its reactions show the presence of a keto group and a tertiary nitrogen atom.
(D) Synthesized by condensing \( \gamma \)-methylaminobutyraldehyde with ethylacetoacetate in buffered solution at pH 7.
Choose the correct answer from the options given below: - The key intermediate for the biosynthesis of C6-C3 units is:
- Central Government approved factory premises where Opium alkaloids are processed is situated at:
- Central Government approved factory premises where Opium alkaloids are processed is situated at:
- The key intermediate for the biosynthesis of C6-C3 units is:
View More Questions
Questions Asked in GPAT exam
- If the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist, it is:
- GPAT - 2025
- Drug therapy
- Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing- GPAT - 2025
- Drug therapy
- Match the following:
(1) Schedule FF
(2) Schedule F3
(3) Schedule V
(4) Schedule Y
Descriptions:
(P) Standards of patent and proprietary medicines
(Q) Requirements and guidelines for clinical trials
(R) Standards for sterilized umbilical tapes
(S) Standards for Ophthalmic preparations- GPAT - 2025
- Drug therapy
Match the following Class and their Drug:
(1) Alkylating (P) 5-fluorouracil
(2) Platinum analog (Q) Cisplatin
(3) Antimetabolite (R) Cetuximab
(4) EGF receptor inhibitor (S) Chlorambucil- GPAT - 2025
- Biostatistics and Research Methodology
- Common name of convective transport
- GPAT - 2025
- Pharmaceutical Analysis
View More Questions